Ridderstrle M, Andersen KR, Zeller C et al (2014) Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
While no studies show cancer causation, those with a history of cancer should avoid these compounds due to IGF-1s mitogenic properties
DOI: 10.1177/0310057X251355288 Maselli DB, Lee D, Bi D, Jirapinyo P, Thompson CC, Donnangelo LL, McGowan CE
To begin medically supervised Semaglutide with at-home convenience and ongoing clinician support, explore Concierge MD LAs weight loss program.
If you take Ozempic with other diabetes medications that also lower blood sugar levels, your blood sugar levels might drop too low